Literature DB >> 31755289

The effect of combined diet containing n-3 polyunsaturated fatty acids and silymarin on metabolic syndrome in rats.

M Poruba1, P Anzenbacher, Z Racova, O Oliyarnyk, M Hüttl, H Malinska, I Markova, S Gurska, L Kazdova, R Vecera.   

Abstract

The risk of development of metabolic syndrome can be increased by hypertriglyceridemia. A search for effective therapy is a subject of considerable attention. Therefore, our hypothesis is that the fish oil (containing polyunsaturated fatty acids; n-3 PUFA) in a combination with silymarin can more effectively protect against hypertriglyceridemia-induced metabolic disturbances. The study was conducted using a unique non-obese strain of rats with hereditary hypertriglyceridemia an accepted model of metabolic syndrome. Adult male rats were treated with n-3 PUFA (300 mg/kg/day) without or with 1 % micronized silymarin in a diet for 4 weeks. The treatment with the diet containing n-3 PUFA and silymarin significantly reduced concentrations of serum triglycerides (-45 %), total cholesterol (-18 %), non-esterified fatty acids (-33 %), and ectopic lipid accumulation in skeletal muscle (-35 %) compared to controls. In addition, an increase in Abcg5 and Abcg8 mRNA expression (as genes affecting lipid homeostasis) as well as in protein content of ABCG5 (+78 %) and ABCG8 (+232 %) transporters have been determined in the liver of treated rats. Our findings suggest that this combined diet could be used in the prevention of hypertriglyceridemia-induced metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31755289     DOI: 10.33549/physiolres.934322

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  4 in total

1.  The combination of atorvastatin with silymarin enhances hypolipidemic, antioxidant and anti-inflammatory effects in a rat model of metabolic syndrome.

Authors:  I Marková; H Malínská; M Hüttl; D Miklánková; O Oliyarnyk; M Poruba; Z Rácová; L Kazdová; R Večeřa
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

2.  Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.

Authors:  Hana Malinská; Martina Hüttl; Denisa Miklánková; Jaroslava Trnovská; Iveta Zapletalová; Martin Poruba; Irena Marková
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs.

Authors:  Maciej Gogulski; Adam Cieślak; Julia Grabska; Marie Ardois; Małgorzata Pomorska-Mól; Paweł A Kołodziejski; Kacper Libera; Viola Strompfová; Małgorzata Szumacher-Strabel
Journal:  BMC Vet Res       Date:  2021-06-26       Impact factor: 2.741

4.  The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.

Authors:  Martina Hüttl; Irena Markova; Denisa Miklankova; Iveta Zapletalova; Martin Poruba; Zuzana Racova; Rostislav Vecera; Hana Malinska
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.